CORRECTION OF MORPHOFUNCTIONAL DISORDERS IN EXPERIMENTAL PREECLAMPSY BY COMBINED USE OF TRIMETAZIDINE AND PURIFIED MICRONIZED FLAVONOID FRACTION AS WELL AS THEIR COMBINATIONS WITH METHYLAMPSY

The aim of the experiment was to determine the effectiveness of the combined use of trimetazidine and a purified micronized flavonoid fraction, as well as their combinations with methyldopa, in comparison with monotherapy with the same drugs in the correction of morphofunctional disorders arising in...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	O. E. Antsiferova, M. P. Teleshchenko, Yu. M. Tsuverkalova, M. V. Pokrovsky, V. V. Gureev, M. A. Zatolokina, A. V. Gureeva
Formatua:	Artigo
Hizkuntza:	Russo
Argitaratua:	Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2021-03-01
Saila:	Фармация и фармакология (Пятигорск)
Gaiak:	trimetazidine purified micronized flavonoid fraction preeclampsia endothelial dysfunction rats
Sarrera elektronikoa:	https://www.pharmpharm.ru/jour/article/view/737
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!